MedPath

THE BRIGHAM AND WOMEN'S HOSPITAL, INC.

THE BRIGHAM AND WOMEN'S HOSPITAL, INC. logo
🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Trial of Feedback on Blood Use

Not Applicable
Terminated
Conditions
Compliance With Restrictive RBC Transfusion Guideline
Interventions
Behavioral: Feedback
First Posted Date
2014-09-05
Last Posted Date
2020-05-18
Lead Sponsor
Brigham and Women's Hospital
Target Recruit Count
426
Registration Number
NCT02232568
Locations
🇺🇸

Richard Kaufman MD, Boston, Massachusetts, United States

🇺🇸

Temple University, Philadelphia, Pennsylvania, United States

🇺🇸

University of Minnesota, Minneapolis, Minnesota, United States

and more 2 locations

Safety and Cardiovascular Efficacy of Hydralazine and Isosorbide Dinitrate in Dialysis-Dependent ESRD

Phase 4
Completed
Conditions
Chronic Hemodialysis (ESRD)
Interventions
Drug: Hydralazine/Isorsorbide Dinitrate
Drug: Placebo
First Posted Date
2014-08-29
Last Posted Date
2021-04-27
Lead Sponsor
Brigham and Women's Hospital
Target Recruit Count
17
Registration Number
NCT02228408
Locations
🇺🇸

Brigham & Women's Hospital, Boston, Massachusetts, United States

Clinical Neuropharmacology of Pain in Spinal Cord Injury- Dextromethorphan/Lidocaine Combination Clinical Trial

Phase 2
Completed
Conditions
Central Neuropathic Pain
Allodynia
Spinal Cord Injury
Interventions
Drug: Placebo (Dextromethorphan)
Drug: Placebo (Lidocaine)
First Posted Date
2014-08-18
Last Posted Date
2018-03-22
Lead Sponsor
Brigham and Women's Hospital
Target Recruit Count
26
Registration Number
NCT02218203
Locations
🇺🇸

Translational Pain Research, Brigham and Women's Hospital, Boston, Massachusetts, United States

Deferoxamine to Prevent Delayed Cerebral Ischemia After Subarachnoid Hemorrhage

Early Phase 1
Terminated
Conditions
Subarachnoid Hemorrhage
Interventions
First Posted Date
2014-08-15
Last Posted Date
2015-07-21
Lead Sponsor
Brigham and Women's Hospital
Target Recruit Count
2
Registration Number
NCT02216513
Locations
🇺🇸

Brigham and Women's Hospital, Boston, Massachusetts, United States

Evaluation of Catheter Placement for Renal Replacement Therapy in Patients With Acute Kidney Injury

Completed
Conditions
Acute Kidney Injury
First Posted Date
2014-07-25
Last Posted Date
2015-07-21
Lead Sponsor
Brigham and Women's Hospital
Target Recruit Count
150
Registration Number
NCT02200120
Locations
🇺🇸

Brigham and Women's Hospital, Boston, Massachusetts, United States

Combined Medication for Improved Analgesia in Superficial Pain

Phase 3
Completed
Conditions
Pain
Interventions
First Posted Date
2014-07-18
Last Posted Date
2018-07-03
Lead Sponsor
Brigham and Women's Hospital
Target Recruit Count
100
Registration Number
NCT02194088
Locations
🇺🇸

Brigham And Women's Hospital, Boston, Massachusetts, United States

Does 3D Laparoscopy Improve Vaginal Cuff Suture Time?

Not Applicable
Completed
Conditions
Abnormal Uterine Bleeding
Pelvic Pain
Adenomyosis
Uterine Fibroids
Interventions
Device: Storz 3D Laparoscopy System
Device: 2D Laparoscopy
First Posted Date
2014-07-17
Last Posted Date
2018-01-24
Lead Sponsor
Brigham and Women's Hospital
Target Recruit Count
57
Registration Number
NCT02192606
Locations
🇺🇸

Brigham & Women's Hospital, Boston, Massachusetts, United States

🇩🇰

Odense University Hospital, Odense, Denmark

Incidence of Difficult Airway and Difficult Neuraxial Placement in Obstetric Patients

Conditions
Indication for Care or Intervention Related to Labor or Delivery With Baby Delivered
First Posted Date
2014-07-17
Last Posted Date
2022-08-03
Lead Sponsor
Brigham and Women's Hospital
Target Recruit Count
400
Registration Number
NCT02193542
Locations
🇺🇸

Brigham and Women's Hospital, Boston, Massachusetts, United States

Tau Imaging of Chronic Traumatic Encephalopathy

Phase 2
Completed
Conditions
Chronic Traumatic Encephalopathy
Interventions
Radiation: [F18]-T807
Radiation: [F18]-Florbetapir
Device: MRI/MRS
Genetic: Genetic Analysis for Genetic Risk Score for Tau.
First Posted Date
2014-07-16
Last Posted Date
2018-05-17
Lead Sponsor
Brigham and Women's Hospital
Target Recruit Count
30
Registration Number
NCT02191267
Locations
🇺🇸

Brigham and Women's Hospital, Boston, Massachusetts, United States

🇺🇸

Boston University Medical Center, Boston, Massachusetts, United States

Safety and Efficacy of Saxagliptin for Glycemic Control in Non-Critically Ill Hospitalized Patient

Phase 4
Completed
Conditions
Diabetes Mellitus
Interventions
First Posted Date
2014-07-08
Last Posted Date
2017-06-23
Lead Sponsor
Brigham and Women's Hospital
Target Recruit Count
72
Registration Number
NCT02182895
Locations
🇺🇸

Brigham and Women's Hospital, Boston, Massachusetts, United States

© Copyright 2025. All Rights Reserved by MedPath